https://www.fiercepharma.com/pharma/novo-nordisk-makes-headway-bid-to-rule-obesity-market-stunning-phase-3-semaglutide-data https://www.clinicaltrialsarena.com/news/novo-nordisk-semaglutide-weight/ Presently, Novo Nordisk estimates that fewer than 65 million people globally, of the total assumed sample of 650 million persons that are non diabetic and have an estimated 30+ BMI (body mass index) are utilizing any sort of…